The effect of mirtazapine in patients with chronic pain and concomitant depression

References

• Breivik H, Collett B, Ventafridda V, et al. Survey of chronic pain in Europe: prevalence, impact on daily life, and treatment. Eur J Pain 2005; [Epub ahead of print (8 August); doi: 10.1016/j.ejpain.2005.06.009]
   Google Scholar
• Rabe-Jablonska J, Miller A. Links between pain and depression. Psychiatr Pol 2005;39:7–20
   Google Scholar
• Magni G. The use of antidepressants in the treatment of chronic pain: a review of the current evidence. Drugs 1991;42:730–48
   PubMed Web of Science ®Google Scholar
• Onder G, Landi F, Gambassi G, et al. Association between pain and depression among older adults in Europe: results from the Aged in Home Care (AdHOC) project: a cross-sectional study. J Clin Psychiatry 2005;66:982–8
   PubMed Web of Science ®Google Scholar
• Gaynes BN, Burns BJ, Tweed DL, Erickson P. Depression and health-related quality of life. J Nerv Ment Dis 2000;190:799–806
   Web of Science ®Google Scholar
• Lance JW, Curran DA. Treatment of chronic tension headache. Lancet 1964;42:1236–9
   Google Scholar
• Kuhn R. The treatment of depressive states with G 22355 (imipramine hydrochloride). Am J Psychiatry 1958;115:459–64
   PubMed Web of Science ®Google Scholar
• Blumer D, Heilbronn M, Pedraza E, Pope G. Systematic treatment of chronic pain with antidepressants. Henry Ford Hosp Med J 1980;28:15–21
   PubMedGoogle Scholar
• Onghena P, Van Houdenhove B. Antidepressant-induced analgesia in chronic non-malignant pain: a meta-analysis of 39 placebo-controlled studies. Pain 1992;52:247–9
   Google Scholar
• Collins SL, Andrew RA, McQuay HJ, Wiffen P. Antidepressants and anticonvulsants for diabetic neuropathy and postherpetic neuralgia. A quantitative systematic review. J Pain Symptom Manage 2000;20:449–58
   PubMed Web of Science ®Google Scholar
• Lynch ME. Antidepressants as analgesics: a review of randomized controlled trials. J Psychiatry Neurosci 2001;26:30–6
   PubMed Web of Science ®Google Scholar
• Basbaum AI, Fields HL. Endogenous pain control systems: brainstem spinal pathways and endorphin circuitry. Annu Rev Neurosci 1984;7:309–38
   PubMed Web of Science ®Google Scholar
• McQuay HJ, Tramer M, Nye BA, et al. A systematic review of antidepressants in neuropathic pain. Pain 1996;68:1080–192
   Google Scholar
• Smith AJ. The analgesic effects of selective serotonin reuptake inhibitors. J Psychopharmacol 1998;12:407–13
   PubMed Web of Science ®Google Scholar
• Fishbain DA, Cutler R, Rosomoff HL, Rosomoff RS. Evidence- based data from animal and human experimental studies on pain relief with antidepressants: a structured review. Pain Med 2000;1:310–6
   PubMed Web of Science ®Google Scholar
• Staiger TO, Gaster B, Sullivan MD, Deyo RA. Systematic review of antidepressants in the treatment of chronic low back pain. Spine 2003;28:2540–5
   PubMed Web of Science ®Google Scholar
• Burke WJ. Selective versus multi-transmitter antidepressants: are two mechanisms better than one? J Clin Psychiatry 2004;65(Suppl 4):37–45
   PubMedGoogle Scholar
• Timmer CJ, Sitsen JM, Delbressine LP. Clinical pharmaco- kinetics of mirtazapine. Clin Pharmacokinet 2000;38:461–74
   PubMed Web of Science ®Google Scholar
• Anttila SA, Leinonen EV. A review of the pharmacological and clinical profile of mirtazapine. CNS Drug Rev 2001;249–64
   PubMedGoogle Scholar
• Montgomery SA. Safety of mirtazapine: a review. Int Clin Psychopharmacol 1995;10(Suppl 4):37–45
   PubMedGoogle Scholar
• Fawcett J, Barkin RL. Review of the results from clinical studies on the efficacy, safety and tolerability of mirtazapine for the treatment of patients with major depression. J Affect Disord 1998;51(3):267–85
   PubMed Web of Science ®Google Scholar
• Schreiber S, Rigai T, Katz Y, Pick CG. The antinociceptive effect of mirtazapine in mice is mediated through serotonergic, noradrenergic and opioid mechanisms. Brain Res Bull 2002;58:601–5
   PubMed Web of Science ®Google Scholar
• Bendtsen L, Jensen R. Mirtazapine is effective in the prophylactic treatment of chronic tension-type headache. Neurology 2004;62:1706–11
   PubMed Web of Science ®Google Scholar
• Theobald DE, Kirsh KL, Holtsclaw E, et al. An open-label, crossover trial of mirtazapine (15 and 30 mg) in cancer patients with pain and other distressing symptoms. J Pain Symptom Manage 2002;23:442–7
   PubMed Web of Science ®Google Scholar
• Davis MP, Khawam E, Pozuelo L, Lagman R. Management of symptoms associated with advanced cancer: olanzapine and mirtazapine [A World Health Organization project]. Expert Rev Anticancer Ther 2002;2:365–76
   PubMedGoogle Scholar
• Szegeddi A, Schwertfeger N. Mirtazapine: a review of its clinical efficacy and tolerability. Expert Opin Pharmacother 2005;6:631–41
   PubMed Web of Science ®Google Scholar
• Di Silvestre M, Greggi T, Rulli E, et al. Lumbar disc herniation in the elderly patient. Chir Organi Mov 2001;86:223–30
   PubMedGoogle Scholar
• Kucharzyk DW. A controlled prospective outcome study of implantable electrical stimulation with spinal instrumentation in a high-risk spinal fusion population. Spine 1999;24: 465–8
   PubMed Web of Science ®Google Scholar
• Jylli L, Olsson GL. Procedural pain in a paediatric surgical emergency unit. Acta Paediatr 1995;84:1403–8
   PubMed Web of Science ®Google Scholar
• Leucht S, Engel RR. The relative sensitivity of the Clinical Global Impressions Scale and the Brief Psychiatric Rating Scale in antipsychotic drug trials. Neuropsychopharmacol 2005 [published online 17 August doi:10.1038/sj.npp.1300873]
   Google Scholar
• Khan A, Khan SR, Shankles EB, Polissar NL. Relative sensitivity of the Montgomery-Asberg Depression Rating Scale, the Hamilton Depression rating scale and the Clinical Global Impressions rating scale in antidepressant clinical trials. Int Clin Psychopharmacol 2002;17:281–5
   PubMed Web of Science ®Google Scholar
• Zaider TI, Heimberg RG, Fresco DM, et al. Evaluation of the clinical global impression scale among individuals with social anxiety disorder. Psychol Med 2003;33(4):611–22
   PubMed Web of Science ®Google Scholar
• Montgomery SA, Reimitz PE, Zivkov M. Mirtazapine versus amitriptyline in the long-term treatment of depression: a double- blind placebo-controlled study. Int Clin Psychopharmacol 1998;13:63–73
   Google Scholar
• Kasper S. Clinical efficacy of mirtazapine: a review of meta- analyses of pooled data. Int Clin Psychopharmacol 1995;10 (Suppl 4):25–35
   PubMedGoogle Scholar
• Ohayon MM, Lader MH. Use of psychotropic medication in the general population of France, Germany, Italy, and the United Kingdom. J Clin Psychiatry 2002;63:817–25
   PubMed Web of Science ®Google Scholar
• Unutzer J, Ferrell B, Marmon T. Pharmacotherapy of pain in depressed older adults. J Am Geriatr Soc 2004;52:1916–22
   PubMed Web of Science ®Google Scholar
• Riedel-Heller SG, Matschinger H, Angermeyer MC. Mental disorders – who and what might help? Help-seeking and treatment preferences of the lay public. Soc Psychiatry Psychiatr Epidemiol 2005;40:167–74
   Google Scholar
• Boshuisen ML, Slaap BR, Vester-Blokland ED, den Boer JA. The effect of mirtazapine in panic disorder: an open label pilot study with a single-blind placebo run-in period. Int Clin Psychopharmacol 2001;16:363–8
   Google Scholar
• Sarchiapone M, Amore M, De Risio S, et al. Mirtazapine in the treatment of panic disorder: an open-label trial. Int Clin Psychopharmacol 2003;18:35–8
   PubMed Web of Science ®Google Scholar
• Stahl S, Zivkov M, Reimitz PE, et al. Meta-analysis of randomized, double-blind, placebo-controlled, efficacy and safety studies of mirtazapine versus amitriptyline in major depression. Acta Psychiatr Scand 1997;391(Suppl):22–30
   Google Scholar
• Deakin B, Dursun S. Optimizing antidepressant treatment: efficacy and tolerability. Int Clin Psychopharmacol 2002;17(Suppl 1):S13–S24
   PubMedGoogle Scholar
• Degner D, Grohmann R, Kropp S, et al. Severe adverse drug reactions of antidepressants: results of the German multicentre drug surveillance program AMSP. Pharmacopsychiatry 2004;37(Suppl 1):S39–S45
   PubMedGoogle Scholar
• Saarto T, Wiffen P. Antidepressants for neuropathic pain. Cochrane Database Syst Rev 2005;20:CD005454
   Google Scholar
• Lee MS, Ham B, Kee B, et al. Comparison of efficacy and safety of milnacipran and fluoxetine in Korean patients with major depression. Curr Med Res Opin 2005;21:1369–75
   PubMed Web of Science ®Google Scholar
• Brambilla P, Cipriani A, Hotopf M, Barbui C. Side-effect profile of fluoxetine in comparison with other SSRIs, tricyclic and newer antidepressants: a meta-analysis of clinical trial data. Pharmacopsychiatry 2005;38:69–77
   PubMed Web of Science ®Google Scholar
• Pedersen LH, Nielsen AN, Blackburn-Munro G. Anti-nociception is selectively enhanced by parallel inhibition of multiple subtypes of monoamine transporters in rat models of persistent and neuropathic pain. Psychopharmacology 2005;17:1–11
   Google Scholar
• Bomholt SF, Mikkelsen JD, Blackburn-Monro G. Antinociceptive effects of the antidepressants amitriptyline, duloxetine, mirtazapine and citalopram in animal models of acute, persi- stent and neuropathic pain. Neuropharmacology 2005;48:252–63
   Google Scholar